114 related articles for article (PubMed ID: 8281163)
1. Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome.
König A; Jakubiczka S; Wieacker P; Schlösser HW; Gessler M
Hum Mol Genet; 1993 Nov; 2(11):1967-8. PubMed ID: 8281163
[No Abstract] [Full Text] [Related]
2. A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome.
Sakai A; Tadokoro K; Yanagisawa H; Nagafuchi S; Hoshikawa N; Suzuki T; Kohsaka T; Hasegawa T; Nakahori Y; Yamada M
Hum Mol Genet; 1993 Nov; 2(11):1969-70. PubMed ID: 8281164
[No Abstract] [Full Text] [Related]
3. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
Machin GA
Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
[No Abstract] [Full Text] [Related]
4. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
Nordenskjöld A; Friedman E; Anvret M
Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
[TBL] [Abstract][Full Text] [Related]
5. Inherited WT1 mutation in Denys-Drash syndrome.
Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
[TBL] [Abstract][Full Text] [Related]
6. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of two Japanese cases of Denys-Drash syndrome.
Tsuda M; Sakiyama T; Kitagawa T; Watanabe S; Watanabe T; Takahashi S; Kawaguchi H; Ito K
J Inherit Metab Dis; 1993; 16(5):876-80. PubMed ID: 8295405
[No Abstract] [Full Text] [Related]
8. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
[TBL] [Abstract][Full Text] [Related]
9. "Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome".
Coppes MJ; Clericuzio CL
Med Pediatr Oncol; 1994; 23(4):390. PubMed ID: 8093189
[No Abstract] [Full Text] [Related]
10. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
[TBL] [Abstract][Full Text] [Related]
11. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1.
Coppes MJ; Huff V; Pelletier J
J Pediatr; 1993 Nov; 123(5):673-8. PubMed ID: 8229473
[No Abstract] [Full Text] [Related]
12. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.
Ogawa O; Eccles MR; Yun K; Mueller RF; Holdaway MD; Reeve AE
Hum Mol Genet; 1993 Feb; 2(2):203-4. PubMed ID: 8098976
[No Abstract] [Full Text] [Related]
13. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of two female patients with incomplete Denys-Drash syndrome.
Ohta S; Ozawa T; Shiraga H; Fuse H
Endocr J; 2000 Dec; 47(6):683-7. PubMed ID: 11228042
[TBL] [Abstract][Full Text] [Related]
15. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
Tsuda M; Sakiyama T; Owada M; Chiba Y
Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
[TBL] [Abstract][Full Text] [Related]
16. [Denys-Drash syndrome].
Kohsaka T; Tagawa M; Yamada M
Nihon Rinsho; 2006 Sep; Suppl 3():457-64. PubMed ID: 17022587
[No Abstract] [Full Text] [Related]
17. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
Simms LA; Algar EM; Smith PJ
Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
[TBL] [Abstract][Full Text] [Related]
18. Distinct molecular origins for Denys-Drash and Frasier syndromes.
Poulat F; Morin D; König A; Brun P; Giltay J; Sultan C; Dumas R; Gessler M; Berta P
Hum Genet; 1993 Apr; 91(3):285-6. PubMed ID: 8386697
[TBL] [Abstract][Full Text] [Related]
19. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
[TBL] [Abstract][Full Text] [Related]
20. Atypical clinical presentation of a WT1-related syndrome associated with a novel exon 6 gene mutation.
Dattolo P; Allinovi M; Iatropoulos P; Michelassi S
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23715837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
